exactly, I think it was the company results that pushed the price down, question is, is the company worth 21 million dollars today? if not it will likely adjust further of its own accord, wont need pushing.
- Forums
- ASX - By Stock
- 1AI
- Ann: Results of LCT Parkinsons trial require further analysis
Ann: Results of LCT Parkinsons trial require further analysis, page-74
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.18M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.9¢ | $386 | 42.91K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 163615 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 633746 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 163615 | 0.009 |
12 | 5396180 | 0.008 |
8 | 6360009 | 0.007 |
6 | 2493750 | 0.006 |
4 | 2300000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 633746 | 2 |
0.011 | 1281697 | 10 |
0.012 | 2385405 | 7 |
0.013 | 894768 | 4 |
0.014 | 126665 | 2 |
Last trade - 10.09am 15/07/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online